References
- K. Traynor, D. W. Newton, J. M. Hrushesky and R. J. Reiter, A pharmacist primer on chronotherapeutics, Am. Phar. 32 (1992) 261-269.
- J. Ali, N. Saigal, M. J. Qureshi, S. Baboota and A. Ahuja, Chronopharmaceutics: A promising drug delivery finding of the last two decades, Rec. Pat. Drug Deliv. Formul. 4 (2010) 129-144; DOI: 10.2174/187221110791184962.
- J. Ali, S. Baboota, A. Ahuja and N. Saigal, Distinctive features of »chronotherapeutic« and »pulsatile « drug delivery systems negating the practice of their interchangeable terminology, J. Drug Target. 18 (2010) 413-419; DOI: 10.3109/10611861003587250.
- N. Saigal, S. Baboota, A. Ahuja and J. Ali, Site specific chronotherapeutic drug delivery systems: A patent review, Rec. Pat. Drug Deliv. Formul. 3 (2009) 64-70; DOI: 10.2174/187221109787158328.
- N. Saigal, S. Baboota, A. Ahuja and J. Ali, Multiple-pulse drug delivery system: setting a new paradigm for infectious disease therapy, Expert Opin. Drug Deliv. 6 (2009) 441-452; DOI: 10.1517/17425240902895972.
- A. C. Ross, R. J. MacRae, M. Walther and H. N. Stevens, Chronopharmaceutical drug delivery from a pulsatile capsule device based on programmable erosion, J. Pharm. Pharmacol. 52 (2000) 903-909.
- S. Arora, J. Ali, A. Ahuja, S. Baboota and J. Qureshi, Pulsatile drug delivery system: An approach for controlled drug delivery, Indian J. Pharm. Sci. 86 (2006) 295-300; DOI: 10.4103/0250-474X.26655.
- T. Bussemer, I. Otto and R. Bodmeier, Pulsatile drug-delivery systems, Crit. Rev. Ther. Drug Carrier Syst. 18 (2001) 433-458; DOI: 10.1517/17425240903490401.
- W. A. Craig, Antibiotic selection factors and description of a hospital-based outpatient antibiotic therapy program in the USA, Eur. J. Clin. Microbiol. Infect. Dis. 14 (1995) 636-642; DOI: 10.1007/BF01690745.
- W. A. Craig, Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men, Clin. Infect. Dis. 26 (1998) 1-12; DOI: 10.1086/516284.
- B. Vogelman and W. A. Craig, Kinetics of antimicrobial activity, J. Pediatr. 108 (1986) 835-840; DOI: 10.1016/S0022-3476(86)80754-5.
- S. Holm, I. Odenholt and O. Cars, Paradoxical effects of antibiotics, Scand. J. Infect. Dis. 74 (1991) 113-117.
- United States Pharmacopoeia XXIV, National Formulary XIX, USP Convention, Rockwille (MD) 2000.
- S. Klein, J. Stein and J. Dressman, Site specifie delivery of anti-inflammatory drugs in the gastrointestinal tract: an in vitro release model, J. Pharm. Pharmacol. 57 (2005) 709-719; DOI: 10.1211/0022357056172.